U.S. Autodesk, McKesson, MicroStrategy
May 29 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autodesk, McKesson and Microstrategy, on Wednesday.
HIGHLIGHTS
* Analog Devices Inc ADI.O: Raymond James raises target price to $260 from $215 |
* Autodesk Inc ADSK.O: Baird cuts target price to $289 from $296 |
* Cencora Inc COR.N: Baird raises target price to $280 from $277 |
* McKesson Corp MCK.N: Baird raises target price to $679 from $671 |
* MicroStrategy Inc MSTR.O: Canaccord Genuity raises target price to $2,047 from $1,590 |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Agios Pharmaceuticals Inc AGIO.O: Leerink Partners raises target price to $59 from $49 |
* Akoustis Technologies Inc AKTS.O: Craig-Hallum cuts target price to $0.25 |
* Akoustis Technologies Inc AKTS.O: Craig-Hallum cuts to hold rating |
* Albany International AIN.N: BofA Global Research cuts price objective to $90 from $95 |
* American Airlines AAL.O: Bernstein cuts target price to $18 from $22 |
* American Airlines AAL.O: BofA Global Research cuts price objective to $11 from $12 |
* American Airlines AAL.O: Jefferies cuts target price to $12 from $17 |
* American Airlines AAL.O: Jefferies cuts to hold from buy |
* American Airlines AAL.O: Seaport Research Partners cuts to neutral from buy |
* American Airlines AAL.O: TD Cowen cuts target price to $16 from $18 |
* American Homes 4 Rent AMH.N: Barclays cuts target price to $42 from $43 |
* Analog Devices Inc ADI.O: Raymond James raises target price to $260 from $215 |
* Atmus Filtration Technologies Inc ATMU.N: Northland Capital raises PT to $36 from $34 |
* Atyr pharma Inc LIFE.O: Jonestrading assumes coverage with buy rating; target price $22 |
* Autodesk Inc ADSK.O: Baird cuts target price to $289 from $296 |
* Autodesk Inc ADSK.O: Citigroup cuts target price to $286 from $298 |
* Bank Ozk OZK.O: Citigroup cuts target price to $37 from $57 |
* Bank Ozk OZK.O: Citigroup cuts to sell from buy |
* Booz Allen Hamilton BAH.N: Barclays raises target price to $153 from $135 |
* Booz Allen Hamilton Holding Corp BAH.N: Jefferies raises target price to $185 from $180 |
* Box Inc BOX.N: Morgan Stanley cuts target price to $30 from $32 |
* Box Inc BOX.N: UBS cuts target price to $31 from $34 |
* Braze Inc BRZE.O: Oppenheimer cuts target price to $60 from $75 |
* Cardinal Health Inc CAH.N: Baird raises target price to $129 from $128 |
* Caretrust REIT Inc CTRE.N: Raymond James raises target price to $29 from $27 |
* Caretrust REIT Inc CTRE.N: Wedbush initiates coverage with neutral rating; PT $26 |
* Carnival Corp CCL.N: Truist Securities cuts target price to $17 from $18 |
* Caseys General Stores Inc CASY.O: JP Morgan cuts target price to $298 from $299 |
* Cava Group Inc CAVA.N: Jefferies raises target price to $94 from $72 |
* Cava Group Inc CAVA.N: JP Morgan raises target price to $77 from $64 |
* Cava Group Inc CAVA.N: Morgan Stanley raises target price to $85 from $68 |
* Cava Group Inc CAVA.N: Morgan Stanley raises target price to $85.00 from $68.00 |
* Cava Group Inc CAVA.N: TD Cowen raises target price to $90 from $73 |
* Cava Group Inc CAVA.N: Wedbush raises target price to $90 from $74 |
* Cencora Inc COR.N: Baird raises target price to $280 from $277 |
* Cervomed Inc CRVO.O: Jonestrading initiates coverage with buy rating; target price $70 |
* Chipotle Mexican Grill Inc CMG.N: Truist Securities raises target to $3520 from $3440 |
* Cognition Therapeutics Inc CGTX.O: H.C. Wainwright initiates coverage with buy rating |
* Cognition Therapeutics Inc CGTX.O: H.C. Wainwright initiates coverage with PT $10 |
* Constellation Brands STZ.N: Barclays cuts target price to $288 from $295 |
* Core Scientific Inc CORZ.O: BTIG raises to buy from neutral |
* Crane Co CR.N: BofA Global Research raises price objective to $165 from $140 |
* Crowdstrike Holdings Inc CRWD.O: JP Morgan raises target price to $400 from $371 |
* CubeSmart CUBE.N: BMO cuts to market perform from outperform; cuts PT to $47 from $50 |
* Cytokinetics Inc CYTK.O: Truist Securities cuts target price to $70 from $86 |
* Dell Technologies Inc DELL.N: BofA Global Research ups price objective to $180 from $130 |
* Delta Air Lines Inc DAL.N: Citigroup raises target price to $65.00 from $55.00 |
* Digital Turbine Inc APPS.O: Craig-Hallum cuts target price to $5 from $10 |
* Domo Inc DOMO.O: TD Cowen cuts target price to $8 from $10 |
* Draftkings Inc DKNG.O: Stifel cuts target price to $50 from $51 |
* Duckhorn Portfolio Inc NAPA.N: RBC cuts target price to $11 from $14 |
* Dupont DD.N: UBS raises target price to $98 from $93 |
* Dycom Industries Inc DY.N: BofA Global Research raises price objective to $198 from $160 |
* Elf Beauty Inc ELF.N: Truist Securities raises target price to $210 from $200 |
* First Solar Inc FSLR.O: RBC raises target price to $315 from $195 |
* First Solar Inc FSLR.O: UBS raises target price to $350 from $270 |
* Five Below Inc FIVE.O: Citigroup cuts target price to $185 from $210 |
* Fortrea Holdings Inc FTRE.O: TD Cowen initiates coverage with hold rating; PT $27 |
* Globus Medical Inc GMED.N: BTIG raises target price to $72 from $63 |
* GoDaddy Inc GDDY.N: JP Morgan raises target price to $175 from $136 |
* Heico Corp HEI.N: Vertical Research raises target price to $245 from $226 |
* Hireright Holdings Corp HRT.N: Jefferies raises target price to $14 from $11 |
* HNI Corp HNI.N: Benchmark raises target price to $57 from $54 |
* Ikena Oncology Inc IKNA.O: Wedbush cuts target price to $2 from $8 |
* Ikena Oncology Inc IKNA.O: Wedbush cuts to neutral from outperform |
* Ikena Oncology Inc IKNA.O: H.C. Wainwright cuts target price to $4 from $11 |
* Independent Bank Group Inc IBTX.O: Truist Securities cuts to hold from buy |
* Independent Bank Group Inc IBTX.O: Truist Securities raises target to $50 from $46 |
* Insmed Inc INSM.O: Barclays raises target price to $63 from $40 |
* Insmed Inc INSM.O: BofA Global Research raises price objective to $62 from $40 |
* Insmed Inc INSM.O: H.C. Wainwright raises target price to $70 from $52 |
* Insmed Inc INSM.O: JP Morgan raises target price to $55 from $36 |
* Insmed Inc INSM.O: TD Cowen raises target price to $67 from $45 |
* Insmed Inc INSM.O: Truist Securities raises target price to $68 from $48 |
* Insmed Inc INSM.O: UBS raises target price to $58 from $46 |
* Insmed Inc INSM.O: Wells Fargo raises target price to $77 from $55 |
* Invitation Homes INVH.N: Barclays cuts target price to $40 from $41 |
* JetBlue Airways Corp JBLU.O: Citigroup cuts target price to $6.50 from $6.90 |
* Liberty Energy Inc LBRT.N: Citigroup raises target price to $32 from $24 |
* Liberty Energy Inc LBRT.N: Citigroup raises to buy from neutral |
* Live Nation Entertainment Inc LYV.N: JP Morgan cuts target price to $116 from $126 |
* LSB Industries Inc LXU.N: Deutsche Bank raises target price to $11 from $9 |
* McKesson Corp MCK.N: Baird raises target price to $679 from $671 |
* Medpace Holdings Inc MEDP.O: TD Cowen initiates with buy rating; target price $452 |
* MicroStrategy Inc MSTR.O: Canaccord Genuity raises target price to $2,047 from $1,590 |
* Mind Medicine (Mindmed) Inc MNMD.O: Baird initiates with outperform rating; PT $27 |
* Molson Coors Beverage Company TAP.N: Barclays cuts target price to $55 from $62 |
* Mongodb Inc MDB.O: Citigroup cuts target price to $480 from $500 |
* Monro Inc MNRO.O: Jefferies cuts target price to $25 from $28 |
* MYR Group Inc MYRG.O: Baird cuts target price to $170 from $180 |
* Nexpoint Residential Trust Inc NXRT.N: Truist Securities cuts target to $34 from $35 |
* Norwegian Cruise Line Holdings Ltd NCLH.N: Truist Securities raises PT to $21 from $20 |
* Norwegian Cruise Line Holdings Ltd NCLH.N: Truist Securities raises to buy from hold |
* Palomar Holdings Inc PLMR.O: Evercore ISI raises target price to $89 from $88 |
* Palomar Holdings Inc PLMR.O: Jefferies raises target price to $98 from $95 |
* Palomar Holdings Inc PLMR.O: KBW raises target price to $96 from $93 |
* Palomar Holdings Inc PLMR.O: Truist Securities raises target price to $100 from $97 |
* PDF Solutions Inc PDFS.O: D.A. Davidson raises target price to $42 from $40 |
* Phillips Edison & Co Inc PECO.O: Deutsche Bank cuts target price to $38 from $41 |
* RBC Bearings Inc RBC.N: William Blair resumes coverage with outperform rating |
* Resources Connection Inc RGP.O: Noble Capital initiates coverage with outperform rating |
* Resources Connection Inc RGP.O: Noble Capital initiates coverage with target price $15 |
* RLJ Lodging Trust RLJ.N: Baird cuts target price to $13 from $14 |
* Royal Caribbean Group RCL.N: Truist Securities raises target price to $175 from $151 |
* Rush Street Interactive Inc RSI.N: Craig-Hallum raises target price to $11 from $10 |
* Sage Therapeutics Inc SAGE.O: Baird initiates coverage with neutral rating and $15 PT |
* Skyline Champion Corp. SKY.N: Barclays cuts target price to $68 from $76 |
* Surmodics Inc SRDX.O: Needham cuts to hold from buy |
* Telephone and Data Systems Inc TDS.N: JP Morgan cuts target price to $34 from $36 |
* TKO Group TKO.N: JP Morgan raises target price to $126 from $103 |
* TransDigm Group TDG.N: BofA Global Research raises price objective to $1,460 from $1,310 |
* Triumph Group Inc TGI.N: Barclays cuts target price to $18 from $20 |
* Triumph Group Inc TGI.N: TD Cowen cuts target price to $14 from $19.5 |
* Triumph Group Inc TGI.N: TD Cowen cuts to hold from buy |
* Uipath Inc PATH.N: Scotiabank cuts target price to $25 from $30 |
* United Airlines UAL.O: Citigroup raises target price to $96 from $80 |
* United Airlines UAL.O: Jefferies raises target price to $65 from $54 |
* United Airlines UAL.O: Jefferies raises to buy from hold |
* United States Cellular Corp USM.N: JP Morgan raises target price to $69 from $51 |
* Veeva Systems Inc VEEV.N: Citigroup raises target price to $274 from $268 |
* Verastem Inc VSTM.O: Alliance Global Partners cuts target price to $20 from $34 |
* Xenia Hotels & Resorts Inc XHR.N: Baird raises target price to $16 from $14 |
* Zscaler Inc ZS.O: BMO cuts target price to $192 from $255 |
* Zscaler Inc ZS.O: UBS cuts target price to $270 from $300 |
(Compiled by Bengaluru Newsroom)
</body></html>Ativos relacionados
Últimas notícias
Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.
Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.
Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.
